The Effect of Aromatherapy to Women With Vasomotor Complaints on Menopausal Quality of Life and Vasomotor Symptoms (Aromatherapy)

September 12, 2023 updated by: Gülsen Müsteyde Altan, Eastern Mediterranean University

The Effect of Aromatherapy to Women With Vasomotor Complaints on Menopausal Quality

Evaluation of the effect of aromatherapy applied to women with vasomotor complaints on menopausal quality of life and vasomotor symptoms.

Study Overview

Detailed Description

Menopause, ovarian failure due to loss of follicular function of the ovaries accompanied by estrogen deficiency, causes permanent cessation of menstruation and loss of reproductive function. The period in which irregularities in the menstrual cycle begin to appear and the chance of fertility decreases is defined as the premenopausal period. During this period, vasomotor complaints occur. vasomotor complaints; It is reported as hot flashes, sweating and night sweats . It has been reported that women experience an average of 4-5 hot flashes per day , and this number reaches 20 in some women . These changes are usually the most severe and disturbing findings two or three years before menopause and can continue in later years . Studies have reported that vasomotor complaints negatively affect women's quality of life.

Application methods of aromatherapy with many therapeutic benefits, massage oil, face cream/oil, gel, body bath, hand and foot baths, compresses, hot towels, aromatic sprays, bath salt, inhalations (direct bottle, sniffing salt, drip on handkerchief), steam inhalation, facial mist, diffusion (diffuser, nebulizer, candle), ointment, mouthwash . Studies have also reported that aromatherapy methods used during menopause reduce vasomotor complaints and positively affect quality of life .

Evaluating and supporting women in line with the holistic nursing approach is among the responsibilities of nurses. Nurses' development of appropriate care standards in line with these goals constitutes an important step for women to step into a healthy and high-quality old age. Women's health nurses should provide care, counseling and training to increase the quality of life of women who spend one-third of their life in the menopausal period .

Studies have reported that aromatherapy has a positive effect on quality of life. However, studies on this subject in Türkiye and the Turkish Republic of Northern Cyprus are quite limited.

Purpose of the research; This study will be conducted to evaluate the effect of aromatherapy applied to women with vasomotor complaints on menopausal quality of life and vasomotor symptoms.

The population of the study will consist of women living in the Turkish Republic of Northern Cyprus, Famagusta District and reporting more than 5 vasomotor complaints according to the Visual Analog Scale. The sample size was determined as 66 by G*Power analysis. Three groups will be formed by randomization method from the people who agreed to participate in the study, while rose oil will be used in the first group, peppermint oil will be used in the second group, and the third group will form the placebo group.

Essential oils to be used in groups to be treated with aromatherapy are rose and mint oils. In addition to the cooling effect of rose oil, it is known that thanks to its pleasant smell, it helps the user to feel good and is also effective in reducing menopausal symptoms. At the same time, peppermint oil is stated to revitalize the body, increase energy level, provide refreshment and reduce menopausal symptoms . It will be used after diluting by adding 10 ml of black cumin oil as carrier oil to 2 drops of rose and mint oils to be used in the study.

In 2021, the researcher completed the 90-hour theoretical and 16-hour applied aromatherapy training program, coordinated by Riccon Academy-Bern-Schweiz and Adamer training center, and received her certificate.

The placebo group will be asked to use the spray whenever they complain of hot flashes, using drinking water.

With this randomized controlled study, it is aimed to evaluate the effect of aromatherapy applied to women with vasomotor complaints on menopausal quality of life and vasomotor symptoms, and to provide evidence for the care to be offered to menopausal women.

Study Type

Interventional

Enrollment (Estimated)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Famagusta, Cyprus, 99628
        • Recruiting
        • Eastern Mediterranean University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being able to speak Turkish,
  • Getting a score above 5 in VAS
  • Not to be allergic to the aromatherapy oils to be applied,
  • Lack of sense of smell,
  • Accepting to work with essential oils to be studied,
  • Not having entered menopause naturally,
  • Not using hormone replacement therapy,
  • Not using complementary alternative therapy,
  • Women who do not have a psychiatric problem,

Exclusion Criteria:

-Wanting to leave the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: rose oil
rose oil will be used
aromatherapy
Experimental: mint oil
mint oil will be used
aromatherapy
Placebo Comparator: plasebo
drinking water will be used
aromatherapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VISUAL ANALOGUE SCALE (VAS)
Time Frame: Baseline, 1 day
VAS is used to convert some values that cannot be measured numerically. This scale is a safe, easily applicable test that has proven itself for a very long time and has been accepted in all the world literature. The test has no language and its ease of implementation is an important advantage. It was used in this study to determine how much hot flashes complaints experienced by women affect their lives. It was explained to the women that one end of the scale did not affect their life at all (0), and that it affected their life too much as they approached the other end (10). The women were asked to mark the number on a divided line with numbers from 0 to 10, and how much they thought their hot flashes had affected their lives.
Baseline, 1 day
Introductory Information Form
Time Frame: Baseline, 1 day
women's socio-demographic characteristics , physical characteristics , pregnancy and birth information (pregnancy). number of people living together, spousal support, menstrual pattern, last menstrual period, age of mother's menopause, chronic diseases, smoking and alcohol use, vasomotor complaints, use of CAM and nursing support are included in a total of 27 questions.
Baseline, 1 day
Hot Flashes Scale Specific to Menopause
Time Frame: Baseline, 1 day, the ninetieth day
The Menopause-Specific Hot Flashes Scale is used to measure the effect of hot flashes on overall quality of life (item 10) and nine specific activities (item 1-item 9). Nine specific activities: work, social activities, leisure activities, sleep, mood, concentration, relationships with others, sexuality, enjoyment of life. How much hot flashes affect the woman's life during the last two weeks is evaluated by numerical rating method from 0 to 10. A value of 0 means "not at all affected" and a value of 10 means "very much affected". The total score is calculated by adding the numerical values of each item.
Baseline, 1 day, the ninetieth day
Menopause-Specific Quality of Life Scale
Time Frame: Baseline, 1 day, the ninetieth day
It is a 29-item Likert-type scale. The scale consists of four domains: vasomotor, psychosocial, physical and sexual. Vasomotor domain (questions 1-3), Psychosocial domain (questions 4-10), Physical space (questions 11-26), Sexual domain (questions 27-29), Each sub-domain score in the scale is ranked from 1 to 8. 1 point indicates that there is no problem with that. A score of 2 indicates that the problem exists, exists, but is not bothersome at all. Scores between 3 and 8 indicate the severity of the existing problem and its increasing degrees.
Baseline, 1 day, the ninetieth day
Aromatherapy Form
Time Frame: 12 week
The usage time and usage amount of the aromatherapy oil will be filled on the aroma therapy form for 12 weeks.
12 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2023

Primary Completion (Estimated)

October 1, 2023

Study Completion (Estimated)

December 31, 2023

Study Registration Dates

First Submitted

June 8, 2023

First Submitted That Met QC Criteria

September 12, 2023

First Posted (Actual)

September 13, 2023

Study Record Updates

Last Update Posted (Actual)

September 13, 2023

Last Update Submitted That Met QC Criteria

September 12, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • EasternMU-SBF-HB-GMAD-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe